Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Disease eradication as a public health strategy: a case study of poliomyelitis eradication
Autore:
Aylward, RB; Hull, HF; Cochi, SL; Sutter, RW; Olive, JM; Melgaard, B;
Indirizzi:
WHO, Vaccines & Biol, Expanded Programme Immunizat, CH-1211 Geneva 27, Switzerland WHO Geneva Switzerland 27 amme Immunizat, CH-1211 Geneva 27, Switzerland Ctr Dis Control & Prevent, Natl Immunizat Program, Vaccine Preventable DisEradicat Div, Atlanta, GA 30333 USA Ctr Dis Control & Prevent Atlanta GA USA 30333 Div, Atlanta, GA 30333 USA
Titolo Testata:
BULLETIN OF THE WORLD HEALTH ORGANIZATION
fascicolo: 3, volume: 78, anno: 2000,
pagine: 285 - 297
SICI:
0042-9686(2000)78:3<285:DEAAPH>2.0.ZU;2-F
Fonte:
ISI
Lingua:
ENG
Soggetto:
VITAMIN-A SUPPLEMENTATION; WILD POLIOVIRUS TYPE-1; ETHICAL DILEMMAS; PARALYTIC POLIOMYELITIS; MOLECULAR EPIDEMIOLOGY; DEVELOPING-COUNTRIES; SERIOUS PROBLEM; VACCINE; CHILD;
Keywords:
cost-benefit analysis; immunization programmes; case studies; and organization and administration; poliomyelitis; prevention and control; programme evaluation;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
79
Recensione:
Indirizzi per estratti:
Indirizzo: Aylward, RB WHO, Vaccines & Biol, Expanded Programme Immunizat, CH-1211 Geneva 27, Switzerland WHO Geneva Switzerland 27 at, CH-1211 Geneva 27, Switzerland
Citazione:
R.B. Aylward et al., "Disease eradication as a public health strategy: a case study of poliomyelitis eradication", B WHO, 78(3), 2000, pp. 285-297

Abstract

Disease eradication as a public health strategy was discussed at international meetings in 1997 and 1998. In this article, the ongoing poliomyelitis eradication initiative is examined using the criteria for evaluating candidate diseases for eradication proposed at these meetings, which covered costs and benefits, biological determinants of eradicability (technical feasibility) and societal and political considerations (operational feasibility). The benefits of poliomyelitis eradication are shown to include a substantial investment in health services delivery, the elimination of a major cause of disability, and far-reaching intangible effects, such as establishment of a "culture of prevention". The costs are found to be financial and finite, despite some disturbances to the delivery of other health services. The "technical" feasibility of poliomyelitis eradication is seen in the absence of a non-human reservoir and the presence of both an effective interventionand delivery strategy (oral poliovirus vaccine and national immunization days) and a sensitive and specific diagnostic tool (viral culture of specimens from acute flaccid paralysis cases). The certification of poliomyelitis eradication in the Americas in 1994 and interruption of endemic transmission in the Western Pacific since March 1997 confirm the operational feasibility of this goal. When the humanitarian, economic and consequent benefits ofthis initiative are measured against the costs, a strong argument is made for eradication as a valuable disease control strategy.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 28/09/20 alle ore 17:59:19